Gilmour Morrison
Impact in
- Pharmacology top 0.5%
- Cannabis and Cannabinoid Research
- Psychiatry and Mental health top 5%
- Epilepsy research and treatment
- Bipolar Disorder and Treatment
Papers in
- Pharmacology 13
- Cannabis and Cannabinoid Research 13
-
- Epilepsy research and treatment 10
- Bipolar Disorder and Treatment 3
- Co-authors
- Bola Tayo (5 shared papers)Graham Blakey (3 shared papers)Lesley Taylor (4 shared papers)Julie C. Crockett (5 shared papers)Barry E. Gidal (3 shared papers)Kenneth W. Sommerville (3 shared papers)Elizabeth A. Thiele (3 shared papers)Orrin Devinsky (3 shared papers)
- Journals
- Neurology (4 papers)The Journal of Clinical Pharmacology (2 papers)CNS Drugs (2 papers)Epilepsia (2 papers)Cancer Research (1 paper)
- Partner nations
- United KingdomUnited StatesSweden
In The Last Decade
Gilmour Morrison
16 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 73
- Pharmacology 1.0k
- Psychiatry and Mental health 436
- Toxicology 81
- Cellular and Molecular Neuroscience 297
- Endocrinology, Diabetes and Metabolism 170
Countries citing papers authored by Gilmour Morrison
This map shows the geographic impact of Gilmour Morrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilmour Morrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilmour Morrison more than expected).
Fields of papers citing papers by Gilmour Morrison
This network shows the impact of papers produced by Gilmour Morrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilmour Morrison. The network helps show where Gilmour Morrison may publish in the future.
Co-authors
The 25 scholars most cited alongside Gilmour Morrison, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects Hit paper breakdown → | 2018 | 341 |
| 2 | Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome Hit paper breakdown → | 2018 | 340 |
| 3 | 2019 | 162 | |
| 4 | 2019 | 83 | |
| 5 | 2020 | 59 | |
| 6 | 2020 | 49 | |
| 7 | 2019 | 46 | |
| 8 | 2020 | 40 | |
| 9 | 2020 | 37 | |
| 10 | 2020 | 29 | |
| 11 | 1990 | 6 | |
| 12 | 2015 | 5 | |
| 13 | 2019 | 3 | |
| 14 | 2019 | 2 | |
| 15 | 2018 | 1 | |
| 16 | 2017 | 1 |
About Gilmour Morrison
Gilmour Morrison is a scholar working on Pharmacology, Psychiatry and Mental health, Pediatrics, Perinatology and Child Health, Endocrinology, Diabetes and Metabolism and Pathology and Forensic Medicine, having authored 16 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (13 papers), Epilepsy research and treatment (10 papers), Pharmacological Effects and Toxicity Studies (6 papers), Diet, Metabolism, and Disease (3 papers), Bipolar Disorder and Treatment (3 papers), Drug Transport and Resistance Mechanisms (2 papers), Poisoning and overdose treatments (1 paper) and Hemoglobinopathies and Related Disorders (1 paper). The work is most often cited by research in Pharmacology (1.0k citations), Psychiatry and Mental health (436 citations), Toxicology (81 citations), Cellular and Molecular Neuroscience (297 citations) and Endocrinology, Diabetes and Metabolism (170 citations). Gilmour Morrison has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Bola Tayo, Graham Blakey, Lesley Taylor, Julie C. Crockett, Barry E. Gidal, Kenneth W. Sommerville, Elizabeth A. Thiele, Orrin Devinsky, David Critchley and Kevan VanLandingham. Their work appears in journals such as Neurology, The Journal of Clinical Pharmacology, CNS Drugs, Epilepsia and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.